Evidence map›Paper›PMID 8291222›Full record

ArticleVirchows Archiv. A, Pathological anatomy and histopathology1993

Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive.

W Domagala, M Markiewski, R Kubiak, J Bartkowiak, M Osborn

Open access · greenAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Virchows Archiv. A, Pathological anatomy and histopathology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Clinical and biological implications of the tumor microenvironment.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2012
    Article
  3. Article
  4. Biological features of premalignant disease in the human breast.Journal of mammary gland biology and neoplasia · 2000
    Review
  5. Article
  6. Article
  7. Prognostic factors in primary breast carcinoma.Journal of clinical pathology · 1995
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

W DomagalaDepartment of Pathology, Medical Academy, Szczecin, Poland.
M Markiewski
R Kubiak
J Bartkowiak
M Osborn
Medical University of Lodz · PLSzczecin Academy of Arts · PLMax Planck Institute for Biophysical Chemistry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vimentin, p53 protein and cathepsin D positivity were assessed by immunohistochemistry, and oestrogen receptor (ER) by an enzyme immunoassay, in invasive lobular carcinomas (LC) of the breast. While vimentin was positive in only 5% (3/57) and p53 protein was positive only in 3% (2/63), cathepsin D was expressed in 86% (48/56) and ER in 78% (25/32). Classical LC were negative for p53 protein and all except one were cathepsin D positive. These results are in contrast to invasive ductal breast carcinomas (DC), where the reported average incidence of vimentin and p53 protein is much higher (19% and 33% respectively) and that of cathepsin D and ER lower (63% and 67% respectively). Thus lack of expression of vimentin and lack of p53 positivity together with high incidence of expression of cathepsin D and ER are more often associated with lobular than with ductal differentiation of invasive breast cancer. The results show that LC, distinguished morphologically, can further be defined by its immunohistochemical profile. This in turn may point to underlying biological differences between LC and DC.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastCarcinoma in SituCarcinoma, LobularCathepsin DFemaleHumansImmunohistochemistryReceptors, EstrogenTumor Suppressor Protein p53VimentinCathepsin DReceptors, EstrogenTumor Suppressor Protein p53Vimentin

Identifiers

PMID8291222
OpenAlexW1979734182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.